Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.

G. Andringa, R.V. van Oosten, W.W.J. Unger, T.G.M. Hafmans, J. Veening, J.C. Stoof, A.R. Cools

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3033-3043
JournalEuropean Journal of Neuroscience
Publication statusPublished - 2000

Cite this